86 related articles for article (PubMed ID: 25384120)
1. Unexpected overestimation of methotrexate plasma concentrations: importance of the assay implementation and its validation.
Godefroid M; Verstraete AG; Stove V
Ther Drug Monit; 2015 Jun; 37(3):417-8. PubMed ID: 25384120
[No Abstract] [Full Text] [Related]
2. Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population.
Guerriero E; Simon N; Nelken B; Baldeyrou B; Djobo B; Vasseur M; Allorge D; Décaudin B; Odou P
Ther Drug Monit; 2014 Aug; 36(4):499-504. PubMed ID: 25014075
[TBL] [Abstract][Full Text] [Related]
3. [Methotrexate].
Yamada M
Nihon Rinsho; 1999 Sep; 57 Suppl():421-4. PubMed ID: 10543143
[No Abstract] [Full Text] [Related]
4. [Methotrexate (MTX)].
Yamada M
Nihon Rinsho; 1995 Feb; 53 Su Pt 1():1053-5. PubMed ID: 8753620
[No Abstract] [Full Text] [Related]
5. Multicenter method evaluation of the ARK™ Methotrexate Immunoassay.
Godefroid MJ; von Meyer A; Parsch H; Streichert T; Verstraete AG; Stove V
Clin Chem Lab Med; 2014 Feb; 52(2):e13-6. PubMed ID: 24114913
[No Abstract] [Full Text] [Related]
6. Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia.
Thachil J
Leuk Res; 2007 Oct; 31(10):1452-3. PubMed ID: 17178159
[No Abstract] [Full Text] [Related]
7. Will nanobiosensors change therapeutic drug monitoring? The case of methotrexate.
Masson JF; Pelletier JN
Nanomedicine (Lond); 2015 Mar; 10(4):521-4. PubMed ID: 25723087
[No Abstract] [Full Text] [Related]
8. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism.
Al-Ghobashy MA; Hassan SA; Abdelaziz DH; Elhosseiny NM; Sabry NA; Attia AS; El-Sayed MH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():88-94. PubMed ID: 27802917
[TBL] [Abstract][Full Text] [Related]
9. Micro-LC-MS/MS: the future of bioanalysis.
Arnold DW; Needham SR
Bioanalysis; 2013 Jun; 5(11):1329-31. PubMed ID: 23742300
[No Abstract] [Full Text] [Related]
10. The advantages of microflow LC-MS/MS compared with conventional HPLC-MS/MS for the analysis of methotrexate from human plasma.
Christianson CC; Johnson CJ; Needham SR
Bioanalysis; 2013 Jun; 5(11):1387-96. PubMed ID: 23742308
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate elimination in a patient with an orthotopic neobladder with and without a urethral catheter.
Wire PD; Dupuis RE; Mohler JL; Bernard SA; Lindley CM
Pharmacotherapy; 1996; 16(5):961-4. PubMed ID: 8888094
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of HPLC method to determination of Methotrexate in children oncologic patients.
De Abreu CC; Rosa PC; Alves Bda C; Azzalis LA; Gehrke Fde S; Pereira EC; Junqueira VB; Perazzo FF; Fonseca FL
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1373-80. PubMed ID: 25967711
[TBL] [Abstract][Full Text] [Related]
13. On-line precolumn derivatization for HPLC determination of methotrexate using a column packed oxidant.
Emara S; Razee S; Khedr A; Masujima T
Biomed Chromatogr; 1997; 11(1):42-6. PubMed ID: 9051216
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate in fibroblastic osteosarcoma.
Chowbay B; Siong KK
Ann Pharmacother; 2001 Dec; 35(12):1669. PubMed ID: 11793640
[No Abstract] [Full Text] [Related]
15. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
[TBL] [Abstract][Full Text] [Related]
16. Rapid determination of methotrexate in plasma by high-performance liquid chromatography with on-line solid-phase extraction and automated precolumn derivatization.
Emara S; Askal H; Masujima T
Biomed Chromatogr; 1998; 12(6):338-42. PubMed ID: 9861494
[TBL] [Abstract][Full Text] [Related]
17. A reversed-phase high performance liquid chromatography method for quantification of methotrexate in cancer patients serum.
Li YD; Li Y; Liang NS; Yang F; Kuang ZP
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():107-12. PubMed ID: 26319303
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
20. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
